Entity Common Stock, Shares Outstanding of OptimizeRx Corp from 30 Jun 2011 to 24 Oct 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
OptimizeRx Corp quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 30 Jun 2011 to 24 Oct 2025.
  • OptimizeRx Corp Entity Common Stock, Shares Outstanding for the quarter ending 24 Oct 2025 was 18,640,652, a 1.2% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

OptimizeRx Corp Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 18,640,652 +219,746 +1.2% 24 Oct 2025 10-Q 07 Nov 2025 2025 Q3
Q2 2025 18,565,033 +243,147 +1.3% 25 Jul 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 18,490,385 +306,471 +1.7% 11 Mar 2025 10-K 20 Mar 2025 2024 FY
Q3 2024 18,420,906 +268,428 +1.5% 08 Nov 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 18,321,886 +1,683,995 +10% 09 Aug 2024 10-Q 15 Aug 2024 2024 Q2
Q1 2024 18,183,914 +1,083,817 +6.3% 12 Apr 2024 10-K 15 Apr 2024 2023 FY
Q3 2023 18,152,478 +999,761 +5.8% 10 Nov 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 16,637,891 -1,385,165 -7.7% 11 Aug 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 17,100,097 -1,052,252 -5.8% 28 Feb 2023 10-K 10 Mar 2023 2022 FY
Q3 2022 17,152,717 -616,827 -3.5% 03 Nov 2022 10-Q/A 10 Mar 2023 2022 Q3
Q2 2022 18,023,056 +404,449 +2.3% 08 Aug 2022 10-Q/A 10 Mar 2023 2022 Q2
Q1 2022 18,152,349 +1,345,712 +8% 29 Apr 2022 10-Q/A 10 Mar 2023 2022 Q1
Q3 2021 17,769,544 +2,660,898 +18% 05 Nov 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 17,618,607 +2,801,746 +19% 30 Jul 2021 10-Q 04 Aug 2021 2021 Q2
Q1 2021 16,806,637 +2,171,026 +15% 03 Mar 2021 10-K 08 Mar 2021 2020 FY
Q3 2020 15,108,646 +934,796 +6.6% 05 Nov 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 14,816,861 +679,498 +4.8% 03 Aug 2020 10-Q 05 Aug 2020 2020 Q2
Q1 2020 14,635,611 +2,540,500 +21% 24 Mar 2020 10-K 26 Mar 2020 2019 FY
Q3 2019 14,173,850 +2,160,168 +18% 01 Nov 2019 10-Q 05 Nov 2019 2019 Q3
Q2 2019 14,137,363 +2,499,817 +21% 03 Aug 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 12,095,111 -17,541,720 -59% 07 Mar 2019 10-K 12 Mar 2019 2018 FY
Q3 2018 12,013,682 -17,261,435 -59% 31 Oct 2018 10-Q 05 Nov 2018 2018 Q3
Q2 2018 11,637,546 -17,618,821 -60% 31 Jul 2018 10-Q 07 Aug 2018 2018 Q2
Q1 2018 29,636,831 -100,786 -0.34% 30 Apr 2018 10-Q 02 May 2018 2018 Q1
Q3 2017 29,275,117 -397,015 -1.3% 31 Oct 2017 10-Q 02 Nov 2017 2017 Q3
Q2 2017 29,256,367 -403,265 -1.4% 28 Jul 2017 10-Q 01 Aug 2017 2017 Q2
Q1 2017 29,737,617 +706,692 +2.4% 30 Apr 2017 10-Q 03 May 2017 2017 Q1
Q3 2016 29,672,132 +653,707 +2.3% 04 Nov 2016 10-Q 07 Nov 2016 2016 Q3
Q2 2016 29,659,632 +6,709,813 +29% 05 Aug 2016 10-Q 08 Aug 2016 2016 Q2
Q1 2016 29,030,925 +29,030,925 10 Mar 2016 10-K 15 Mar 2016 2015 FY
Q3 2015 29,018,425 +5,613,606 +24% 11 Nov 2015 10-Q 12 Nov 2015 2015 Q3
Q2 2015 22,949,819 -412,558 -1.8% 11 Aug 2015 10-Q 11 Aug 2015 2015 Q2
Q1 2015 0 -22,809,586 -100% 31 Mar 2015 10-Q 14 May 2015 2015 Q1
Q3 2014 23,404,819 +8,901,323 +61% 12 Nov 2014 10-Q 13 Nov 2014 2014 Q3
Q2 2014 23,362,377 +9,109,881 +64% 11 Aug 2014 10-Q 14 Aug 2014 2014 Q2
Q1 2014 22,809,586 +8,577,090 +60% 31 Mar 2014 10-K 31 Mar 2014 2013 FY
Q3 2013 14,503,496 +271,000 +1.9% 13 Nov 2013 10-Q 14 Nov 2013 2013 Q3
Q2 2013 14,252,496 +60,000 +0.42% 30 Jun 2013 10-Q 12 Aug 2013 2013 Q2
Q1 2013 14,232,496 +40,000 +0.28% 31 Mar 2013 10-Q 15 May 2013 2013 Q1
Q3 2012 14,232,496 +40,000 +0.28% 30 Sep 2012 10-Q 14 Nov 2012 2012 Q3
Q2 2012 14,192,496 +223,294 +1.6% 30 Jun 2012 10-Q 14 Aug 2012 2012 Q2
Q1 2012 14,192,496 31 Mar 2012 10-Q 15 May 2012 2012 Q1
Q3 2011 14,192,496 14 Nov 2011 10-Q/A 23 Nov 2011 2011 Q3
Q2 2011 13,969,202 30 Jun 2011 10-Q 17 Aug 2011 2011 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.